AIM ImmunoTech, Inc. (AIM)
0.2372
-0.01
(-2.59%)
USD |
NYAM |
May 22, 16:00
0.23
-0.01
(-3.04%)
After-Hours: 20:00
AIM ImmunoTech Total Assets (Quarterly) : 8.585M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 186.46M |
| Curis, Inc. | 29.69M |
| Plus Therapeutics, Inc. | 19.92M |
| Windtree Therapeutics, Inc. | 15.98M |
| Halozyme Therapeutics, Inc. | 2.673B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.46M |
| Shareholders Equity (Quarterly) | 2.125M |
| Debt to Equity Ratio | 2.152 |
| Current Ratio | 1.011 |
| Net Debt Paydown Yield | -16.40% |